CLINICAL TRIALS PROFILE FOR SORBITOL 3.3% IN PLASTIC CONTAINER
✉ Email this page to a colleague
All Clinical Trials for SORBITOL 3.3% IN PLASTIC CONTAINER
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000159 ↗ | Sorbinil Retinopathy Trial (SRT) | Completed | National Eye Institute (NEI) | Phase 3 | 1983-08-01 | To evaluate the safety and efficacy of the investigational drug sorbinil, an aldose reductase inhibitor, in preventing the development of diabetic retinopathy and neuropathy in persons with insulin-dependent diabetes. |
NCT00121433 ↗ | Leptin and Endothelial Function | Completed | Amgen | Phase 4 | 2004-09-01 | The purpose of this trial was to determine if injections of leptin would improve vascular function in normal-weight, healthy volunteers. |
NCT00121433 ↗ | Leptin and Endothelial Function | Completed | University of Michigan | Phase 4 | 2004-09-01 | The purpose of this trial was to determine if injections of leptin would improve vascular function in normal-weight, healthy volunteers. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SORBITOL 3.3% IN PLASTIC CONTAINER
Condition Name
Clinical Trial Locations for SORBITOL 3.3% IN PLASTIC CONTAINER
Trials by Country
Clinical Trial Progress for SORBITOL 3.3% IN PLASTIC CONTAINER
Clinical Trial Phase
Clinical Trial Sponsors for SORBITOL 3.3% IN PLASTIC CONTAINER
Sponsor Name